SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form CORRESP - Correspondence:
SEC Accession No. 0000950170-23-066397
Filing Date
2023-11-28
Accepted
2023-11-28 16:05:05
Documents
4

Document Format Files

Seq Description Document Type Size
1 filename1.htm CORRESP 23081
2 GRAPHIC img48831280_0.jpg GRAPHIC 59344
3 GRAPHIC img48831280_1.jpg GRAPHIC 70528
4 GRAPHIC img48831280_2.jpg GRAPHIC 70528
  Complete submission text file 0000950170-23-066397.txt   299993
Mailing Address 35 GATEHOUSE DRIVE BUILDING D, FLOOR 3 WALTHAM MA 02451
Business Address 35 GATEHOUSE DRIVE BUILDING D, FLOOR 3 WALTHAM MA 02451 781-419-1400
Syndax Pharmaceuticals Inc (Filer) CIK: 0001395937 (see all company filings)

IRS No.: 320162505 | State of Incorp.: DE | Fiscal Year End: 1231
Type: CORRESP
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)